Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein--Barr viraemia T. Martelius, V.-J. Anttila Clinical Microbiology and Infection Volume 16, Issue 6, Pages 657-662 (June 2010) DOI: 10.1111/j.1469-0691.2009.02922.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1 The distribution of peak Epstein–Barr virus (EBV) DNA copy numbers in plasma of immunocompetent and immunosuppressed patients. In the box plots, median, hnterquartile range, extremes and outliers are shown. The y-axis depicts values of EBV DNA in log10 of copies/mL. In addition, dot blots of individual values are shown next to the box plot. When one outlier (patient no. 15 in the immunocompetent group) is removed, the difference is significant (p <0.05, t-test for unequal variances). Clinical Microbiology and Infection 2010 16, 657-662DOI: (10.1111/j.1469-0691.2009.02922.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions